0 Comments New Rule Would Require Breast Density Disclosure A proposed federal rule says that patients must be informed after mammograms if they have dense breasts. by Carly Weeks 0 Comments PARP Inhibitors in Pancreatic Cancer Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer. by Kate Yandell 0 Comments Telling Their Stories Through Posters Survivors and advocates display their posters alongside the work of thousands of cancer researchers. by Kevin McLaughlin 0 Comments The Crowded Field of Checkpoint Inhibitors Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field. by Kate Yandell 0 Comments Drug Costs and Cancer Care Experts discuss the value of cancer treatments in a climate of rising drug prices. by Kevin McLaughlin 0 Comments What Is Hyper-Progression? Some researchers believe that immunotherapy occasionally causes cancer to grow faster, a phenomenon dubbed hyper-progression. by Kate Yandell 0 Comments Risk Reduction, Clinical Trials Are Focus of Atlanta Community Event Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research. by Kevin McLaughlin 0 Comments Sharing Knowledge, Building Community The executive editor of Cancer Today previews the new issue. by Kevin McLaughlin 0 Comments What Not to Say to a Cancer Patient When visiting a friend or family member who is sick, it’s good to leave platitudes at the door. by Michael Gavaghen 0 Comments First Immunotherapy Approved for Breast Cancer Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer. by Anna Azvolinsky next